Blood test may reveal if allergy treatment is effective
NCT ID NCT06876506
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to develop a blood test that measures B regulatory cells, which may indicate whether allergen immunotherapy (allergy shots) is successfully reducing allergic reactions. Researchers will study 80 adults with pollen or venom allergies who are starting routine allergy shots, along with a control group without allergies. Participants will give blood samples and fill out quality-of-life questionnaires to see if changes in these immune cells match improvements in allergy symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Allergen specific immunotherapy (allergy shots)
- What this could lead to
- If successful, this could lead to a simple blood test that tells doctors whether allergy shots are working, helping personalize treatment.
- What could go wrong
- This is an early observational study, not a treatment trial. The blood test may not reliably predict treatment success, and results may not apply to all allergies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLLEN ALLERGY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hull Teaching Hospital NHS Trust
Hull, East Yorkshire, HU3 2JZ, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.